Skip to main content

Table 2 Clinicopathological characteristics of the patients included in the study

From: Immunologic cellular characteristics of the tumour microenvironment of hepatocellular carcinoma drive patient outcomes

Variable Value (%)
No. of patients 58
Gender
 Female 13 (22.4%)
 Male 45 (77.6%)
Patient age (years)
 ≤ 60 21 (36.2%)
 > 60 37 (63.8%)
Pathologic T stage
 T1/T2 29 (50.0%)
 T3/T4 29 (50.0%)
Pathologic N stage
 Positive 11 (19.0%)
 Negative 47 (81.0%)
Lymphangiosis carcinomatosa
 Positive 17 (29.3%)
 Negative 41 (70.7%)
Angioinvasion
 Positive 30 (51.7%)
 Negative 28 (48.3%)
Multiple tumour nodules
 With 13 (22.4%)
 Without 45 (77.6%)
Tumor size (mm)
 ≤ 50 11 (19.0%)
 > 50 47 (81.0%)
Pathologic R category
 R0 49 (84.5%)
 R1/R2 9 (15.5%)
Histologic differentiation
 Well 11 (19.0%)
 Moderate/poor 47 (81.0%)
Distant metastases
 With 11 (19.0%)
 Without 47 (81.0%)
Tumor recurrence
 With 23 (39.7%)
 Without 35 (60.3%)
Local recurrence
 With 17 (29.3%)
 Without 41 (70.7%)